| Citation: | YU Xuanhua, ZHANG Weizhen, LIU Changquan, LYU Xuebing, WU Yueping, CHEN Rongyan, HUANG Huijuan. Changes in peripheral blood lymphocyte subsets in patients with systemic lupus erythematosus correlate with disease activity and predict the value of systemic damage[J]. Chinese Journal of General Practice, 2025, 23(9): 1555-1560. doi: 10.16766/j.cnki.issn.1674-4152.004176 |
| [1] |
方茹梦, 狄宁宁, 郑倩倩, 等. 系统性红斑狼疮患者血清B细胞活化因子表达水平与颈动脉粥样硬化及其相关因素的关系[J]. 中华全科医学, 2022, 20(3): 371-374. doi: 10.16766/j.cnki.issn.1674-4152.002355
FANG R M, DI N N, ZHENG Q Q, et al. Relationship between serum B-cell activating factor expression and carotid atherosclerosis and its related factors in patients with systemic lupus erythematosus[J]. Chinese Journal of General Practice, 2022, 20(3): 371-374. doi: 10.16766/j.cnki.issn.1674-4152.002355
|
| [2] |
LI H, BOULOUGOURA A, ENDO Y, et al. Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies[J]. J Autoimmun, 2022, 132: 102870. DOI: 10.1016/j.jaut.2022.102870.
|
| [3] |
LIN S J, KUO M L, HSIAO H S, et al. Cytotoxic function and cytokine production of natural killer cells and natural killer T-Like cells in systemic lupus erythematosis regulation with interleukin-15[J]. Mediators Inflamm, 2019, 2019: 4236562. DOI: 10.1155/2019/4236562.
|
| [4] |
CHEN P M, TSOKOS G C. The role of CD8+ T-cell systemic lupus erythematosus pathogenesis: an update[J]. Curr Opin Rheumatol, 2021, 33(6): 586-591. doi: 10.1097/BOR.0000000000000815
|
| [5] |
BOMBARDIER C, GLADMAN D D, UROWITZ M B, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE[J]. Arthritis Rheum, 1992, 35(6): 630-640. doi: 10.1002/art.1780350606
|
| [6] |
中华医学会风湿病学分会, 国家皮肤与免疫疾病临床医学研究中心, 中国系统性红斑狼疮研究协作组. 2020中国系统性红斑狼疮诊疗指南[J]. 中华内科杂志, 2020, 59(3): 172-185.
Chinese Rheumatology Association, National Clinical Research Center For Dermatologic And Immunologic Diseases, Chinese Systemic Lupus Erythematosus Treatment And Research Group. 2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus[J]. Chinese Journal of Internal Medicine, 2020, 59(3): 172-185.
|
| [7] |
邹光美, 黄朝任, 陆颖, 等. 系统性红斑狼疮患者T淋巴细胞亚群、补体和血脂水平及其临床意义[J]. 广西医学, 2019, 41(17): 2161-2163, 2170.
ZOU G M, HUANG C R, LU Y, et al. T lymphocyte subsets, complement and lipid levels in systemic lupus erythematosus patients and their clinical significance[J]. Guangxi Medicine, 2019, 41(17): 2161-2163, 2170.
|
| [8] |
陈金, 陈旭艳. T细胞发育在系统性红斑狼疮发病机制中的作用[J]. 中国现代医生, 2020, 58(7): 11-14.
CHEN J, CHEN X Y. The role of T cell development in the pathogenesis of systemic lupus erythematosus[J]. Chinese Modern Doctor, 2020, 58(7): 11-14.
|
| [9] |
路峰, 吉恒东, 孙华, 等. T细胞亚群、IL-6、IL-18及IFN-γ水平变化与系统性红斑狼疮发病的相关性及可能的作用机制分析[J]. 中国医学装备, 2019, 16(3): 88-91.
LU F, JI H D, SUN H, et al. Correlation of T cell subsets, IL-6, IL-18 and IFN-γ levels with the pathogenesis of systemic lupus erythematosus and possible mechanism analysis[J]. Chinese Medical Equipment, 2019, 16(3): 88-91.
|
| [10] |
任雪景, 阎磊, 李纳, 等. T淋巴细胞亚群和血脂水平与系统性红斑狼疮疾病活动度的相关性研究[J]. 中华实用诊断与治疗杂志, 2019, 33(2): 132-135.
REN X J, YAN L, LI N, et al. Correlation between T lymphocyte subsets and blood lipid levels and disease activity in systemic lupus erythematosus[J]. Chinese Journal of Practical Diagnosis and Treatment, 2019, 33(2): 132-135.
|
| [11] |
邵婧. 外周血T淋巴细胞亚群与系统性红斑狼疮患者疾病活动度的相关性[J]. 中国医学工程, 2020, 28(8): 119-121.
SHAO J. Correlation between peripheral blood T lymphocyte subsets and disease activity in systemic lupus erythematosus patients[J]. Chinese Medical Engineering, 2020, 28(8): 119-121.
|
| [12] |
LAI Y, ZHUANG L, ZHU J, et al. Novel approach to alleviate lupus nephritis: targeting the NLRP3 inflammasome in CD8+CD69+CD103+TRM cells[J]. J Transl Med, 2024, 22(1): 1139. DOI: 10.1186/s12967-024-05951-9.
|
| [13] |
冯秀南, 袁艺, 宿凯笙, 等. 系统性红斑狼疮患者外周血T淋巴细胞亚群的分布及其与疾病活动和预后的关系[J]. 吉林大学学报(医学版), 2019, 45(6): 1415-1421.
FENG X N, YUAN Y, SU K S, et al. Distribution of peripheral blood T lymphocyte subsets in systemic lupus erythematosus patients and its relationship with disease activity and prognosis[J]. Journal of Jilin University (Medical Edition), 2019, 45(6): 1415-1421.
|
| [14] |
邢雪, 袁启航, 叶小康, 等. 初治系统性红斑狼疮患者外周血中NK细胞的变化及临床意义[J]. 中国免疫学杂志, 2021, 37(3): 330-334.
XING X, YUAN Q H, YE X K, et al. Changes and clinical significance of NK cells in peripheral blood of patients with initial treatment of systemic lupus erythematosus[J]. Chinese Journal of Immunology, 2021, 37(3): 330-334.
|
| [15] |
KELL L, SHAH K, TAYLOR S, et al. P162 Dimethyl fumarate modulates T cell metabolism and function in systemic lupus erythematosus patient samples[J]. Rheumatology, 2024, 63 (Supple1). DOI: 10.1093/rheumatology/keae163.201.
|
| [16] |
仲华, 王朝辉, 林志强, 等. 系统性红斑狼疮患者外周血CD3-CD16+CD56+NK细胞水平变化的临床意义[J]. 分子诊断与治疗杂志, 2020, 12(11): 1565-1569.
ZHONG H, WANG C H, LIN Z Q, et al. Clinical significance of changes in peripheral blood CD3-CD16+CD56+NK cells in patients with systemic lupus erythematosus[J]. Journal of Molecular Diagnosis and Treatment, 2020, 12(11): 1565-1569.
|